KTOVW (KTOVW)

[KantKill]

Will use the 09/21 as suggested, thanks...

(using this reply for both)


To BostonBull1990's question:

The science I am okay with, and yes I deal in biopharma/biotech industry more often than not, especially plays like this one, and I definitely agree and appreciate as to what BP would pay for a company (and its drug(s)) such as this one - My concern is with the shares, warrants, and exactly what will happen down the road -- For example, if KTOV (usa) is trading at $4 dollars (hypothetical, although its close to current SP), I am correct to assume that it is thus trading with a 15cent premium compared to the KTOV (israel) shares (x20). In other words, the KTOV ADS's trade a 15 cent premium to the value of their underlying 20 ordinary shares traded in Israel. (That is using the current exchange rate for ILS/USD on xe.com, I found a current share price of .73 ILS therefore (.73 x 20 ) = 14.6 converted to USD is 3.85~ thus a 15 cent premium.

I've barely scratched the surface, just want to see if we are on same page thus far...